Defeating Paediatric Tuberculous Meningitis: Applying the WHO "Defeating Meningitis by 2030: Global Roadmap".

Defeating Paediatric Tuberculous Meningitis: Applying the WHO "Defeating Meningitis by 2030: Global Roadmap".
复制标题

DOI:
10.3390/microorganisms9040857
复制
发表时间:
2021-04-16
期刊:
影响因子:
4.5
通讯作者:
Anderson ST
Anderson ST
中科院分区:
生物学3区
文献类型:
--
作者:
Basu Roy R;Bakeera-Kitaka S;Chabala C;Gibb DM;Huynh J;Mujuru H;Sankhyan N;Seddon JA;Sharma S;Singh V;Wobudeya E;Anderson ST

文献摘要

参考文献

被引文献

相似文献

受结核性脑膜炎(TBM)影响的儿童及其家庭的需求处于结核病和脑膜炎临床、研究和政策领域的交叉点。因此,任何一个方案都有可能无法充分满足这些需要。在这篇叙述性评论文章中,我们以世界卫生组织(世卫组织)的“到2030年战胜脑膜炎:全球路线图”为起点,考虑具体战胜儿童结核性脑膜炎的关键目标和活动。我们运用路线图中概述的五个支柱来描述如何调整这一方法,以服务受隧道掘进机影响的儿童。支柱是(i)预防;(二)诊断和治疗;(3)监测;㈣为脑膜炎患者提供支持和护理;(五)倡导和参与。最后,我们呼吁在世卫组织和国家层面加强脑膜炎和结核病规划的整合。
Children affected by tuberculous meningitis (TBM), as well as their families, have needs that lie at the intersections between the tuberculosis and meningitis clinical, research, and policy spheres. There is therefore a substantial risk that these needs are not fully met by either programme. In this narrative review article, we use the World Health Organization (WHO) “Defeating Meningitis by 2030: global roadmap” as a starting point to consider key goals and activities to specifically defeat TBM in children. We apply the five pillars outlined in the roadmap to describe how this approach can be adapted to serve children affected by TBM. The pillars are (i) prevention; (ii) diagnosis and treatment; (iii) surveillance; (iv) support and care for people affected by meningitis; and (v) advocacy and engagement. We conclude by calling for greater integration between meningitis and TB programmes at WHO and at national levels.
DOI: 10.5588/ijtld.15.0253
发表时间: 2015-10
期刊: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
影响因子: --
作者:
Bahr NC;Tugume L;Rajasingham R;Kiggundu R;Williams DA;Morawski B;Alland D;Meya DB;Rhein J;Boulware DR
通讯作者: Boulware DR
DOI: 10.1016/j.eclinm.2020.100603
发表时间: 2020-11
期刊: EClinicalMedicine
影响因子: 15.1
作者:
Cilloni L;Fu H;Vesga JF;Dowdy D;Pretorius C;Ahmedov S;Nair SA;Mosneaga A;Masini E;Sahu S;Arinaminpathy N
通讯作者: Arinaminpathy N
DOI: 10.1128/aac.00319-12
发表时间: 2012-06-01
影响因子: 4.9
作者:
Dau Quang Tho;Toeroek, M. Estee;Caws, Maxine
通讯作者: Caws, Maxine
DOI: 10.12688/wellcomeopenres.15506.1
发表时间: 2019-01-01
影响因子: --
作者:
Cresswell, Fiona V;Davis, Angharad G;Thuong, Nguyen Thuy Thuong
通讯作者: Thuong, Nguyen Thuy Thuong
DOI: 10.1016/s1473-3099(17)30474-7
发表时间: 2018-01
期刊: The Lancet. Infectious diseases
影响因子: --
作者:
Bahr NC;Nuwagira E;Evans EE;Cresswell FV;Bystrom PV;Byamukama A;Bridge SC;Bangdiwala AS;Meya DB;Denkinger CM;Muzoora C;Boulware DR;ASTRO-CM Trial Team
通讯作者: ASTRO-CM Trial Team